ENTITY

Apollomics Inc (1435488D US)

Analysis

Health Care • United States

CBT Pharmaceuticals, Inc. operates as an emerging life sciences oncology company. The Company develops medicines targeting the growth and proliferation of cancer cells. CBT Pharmaceuticals serves customers worldwide.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00